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Abstract
Background: Neuronal nitric oxide synthase (nNOS) is involved in the regulation of a diverse
population of intracellular messenger systems in the brain. In humans, abnormal NOS/nitric oxide
metabolism is suggested to contribute to the pathogenesis and pathophysiology of some
neuropsychiatric disorders, such as schizophrenia and bipolar disorder. Mice with targeted
disruption of the nNOS gene exhibit abnormal behaviors. Here, we subjected nNOS knockout
(KO) mice to a battery of behavioral tests to further investigate the role of nNOS in
neuropsychiatric functions. We also examined the role of nNOS in dopamine/DARPP-32 signaling
in striatal slices from nNOS KO mice and the effects of the administration of a dopamine D1
receptor agonist on behavior in nNOS KO mice.
Results: nNOS KO mice showed hyperlocomotor activity in a novel environment, increased social
interaction in their home cage, decreased depression-related behavior, and impaired spatial
memory retention. In striatal slices from nNOS KO mice, the effects of a dopamine D1 receptor
agonist, SKF81297, on the phosphorylation of DARPP-32 and AMPA receptor subunit GluR1 at
protein kinase A sites were enhanced. Consistent with the biochemical results, intraperitoneal
injection of a low dose of SKF81297 significantly decreased prepulse inhibition in nNOS KO mice,
but not in wild-type mice.
Conclusion: These findings indicate that nNOS KO upregulates dopamine D1 receptor signaling,
and induces abnormal social behavior, hyperactivity and impaired remote spatial memory. nNOS
KO mice may serve as a unique animal model of psychiatric disorders.
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Background
Establishing animal models of psychiatric disorders by
utilizing genetically engineered mice is essential for inves-
tigating the pathogenesis, pathophysiology, and treat-
ment of the disorders [1-5]. Previously, we reported that
forebrain-specific calcineurin (also called protein phos-
phatase 2B) knockout (KO) mice have severe working/
episodic-like memory deficits [6] and exhibit a spectrum
of abnormal behaviors similar to those of schizophrenic
patients [7]. In addition, we identified the PPP3CC gene,
which encodes the calcineurin gamma subunit, as a
potential schizophrenia susceptibility gene [8]. These
studies demonstrated the usefulness of a comprehensive
behavioral test battery for genetically engineered mice to
efficiently evaluate a mouse model of human psychiatric
disorders. Thus, we have applied this approach to test var-
ious strains of mice bearing mutations of genes encoding
molecules involved in calcineurin signaling pathways or
calcineurin-related neural mechanisms [5,9,10]. Here we
focused on neuronal nitric oxide synthase (nNOS), one of
the calcineurin substrates in the nervous system [11,12].
Nitric oxide (NO) is a highly diffusible gas that acts as an
endogenous messenger molecule in various tissues. In the
brain, NO has a variety of important roles, including reg-
ulation of neurotransmission, synaptic plasticity, gene
expression, and neurotoxicity [13-15]. NO is enzymati-
cally synthesized from L-arginine by nitric oxide synthase
(NOS). In the mammalian nervous system, NO is prima-
rily produced by nNOS, an isoform predominantly
expressed in the brain among three NOS isoforms [14].
nNOS is expressed in a discrete population of neurons in
the hippocampus, cortex, striatum, cerebellum, olfactory
bulb, and brain stem [16,17]. nNOS catalytic activity is
regulated by the phosphorylation state of the enzyme. The
phosphorylation of nNOS by protein kinase C (PKC) and
Ca2+/calmodulin-dependent kinases inhibits nNOS activ-
ity [18,19], whereas dephosphorylation by calcineurin
activates nNOS [20]. Direct binding of nNOS to PSD-95
protein induces nNOS to localize at a postsynaptic density
in the vicinity of NMDA receptors, allowing for an effi-
cient and specific activation of nNOS in response to a
glutamate-induced Ca2+ influx [21,22].
The in vivo function of nNOS has been examined using
mice with targeted disruption of the nNOS gene [23].
These mice are viable and exhibit a grossly normal appear-
ance, but their aggressive behavior [24], nocturnal motor
coordination [25], and cognitive performance [26] are
somewhat abnormal. In humans, abnormal nNOS/NO
metabolism is suggested to contribute to the pathogenesis
and pathophysiology of some neuropsychiatric disorders.
In postmortem brain from patients with schizophrenia,
the total number of nNOS-containing neurons in the
hypothalamus is smaller [27] and nNOS-positive striatal
interneurons are decreased [28] compared to normal
cases. Regulatory polymorphisms of nNOS contribute to
the genetic risk for schizophrenia [29] and the nNOS gene
is associated with schizophrenia among Ashkenazi Jewish
case-parent trios [30]. Recently, Walsh et al. reported
more microdeletions and microduplications in the
genome of schizophrenia patients compared to control
samples [31]. The microdeletions and microduplications
in cases disproportionately disrupted genes involved in
some signaling networks, including NO signaling path-
ways [31]. Among the several pathways and processes
overrepresented by disrupted genes in schizophrenia
cases, NO signaling pathways were the most statistically
reliable [31]. In addition, transcription of nitric oxide syn-
thase 1 (neuronal) adaptor protein (NOS1AP) that is also
termed CAPON, was upregulated both in schizophrenia
and bipolar disorder [32]. Binding of NOS1AP to nNOS
results in a reduction of NMDA receptor/NOS complexes,
leading to decreased NMDA receptor-gated calcium influx
and a catalytically inactive nitric oxide synthase [33]. In
agreement, genetic association study revealed that single
nucleotide polymorphisms (SNP) in NOS1AP were asso-
ciated with schizophrenia [34]. The variant with the SNP
altered the expression of the gene by enhancing transcrip-
tion factor binding [34].
The interaction between glutamatergic and dopaminergic
pathways is crucial for cognitive and motor functions, and
both signal transduction pathways are major contributing
factors in schizophrenia pathogenesis [35]. DARPP-32,
which is a 32-kDa dopamine- and cyclic adenosine mono-
phosphate (cAMP)-regulated phosphoprotein, is a critical
signal transduction molecule that integrates glutamatergic
and dopaminergic pathways in medium spiny neurons in
the neostriatum [36,37]. Dopamine, acting through D1
receptors, activates cAMP-dependent protein kinase
(PKA), resulting in the phosphorylation of DARPP-32 at
Thr34 [36,38]. Phosphorylated DARPP-32 is a potent
inhibitor of protein phosphatase-1 [39], and thereby con-
trols the phosphorylation state and activity of many
downstream molecules, such as NMDA receptors, AMPA
receptors, voltage-dependent Na+  channels, and Ca2+
channels [40]. On the other hand, glutamate activates cal-
cineurin, resulting in the dephosphorylation and inactiva-
tion of DARPP-32 [41-43]. Glutamate also activates the
nNOS/NO/cyclic guanine monophosphate (cGMP)/pro-
tein kinase G (PKG) signaling cascade, leading to the
phosphorylation of DARPP-32 at Thr34 [44,45], as
DARPP-32 at Thr34 is an excellent substrate for PKG as
well as for PKA [39]. Moreover, NO may also inhibit
dopamine uptake [46]. Thus, nNOS/NO signaling is
under the control of glutamate, and has an important role
in the regulation of dopaminergic/DARPP-32 signaling.
To assess the possible utility of nNOS KO mice as an ani-
mal model of psychiatric disorders, we subjected them to
a comprehensive behavioral test battery [5,9]. nNOS KOMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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mice showed hyperlocomotor activity in a novel environ-
ment, increased social interaction in their home cage,
decreased depression-related behavior, and impaired spa-
tial memory retention. We also examined a possible role
for nNOS in dopaminergic signaling and revealed an
upregulation of the dopamine-signaling cascade in neos-
triatal slices from nNOS KO mice. The augmenting effect
of D1 agonist administration on sensorimotor gating in
prepulse inhibition (PPI) tests is consistent with an upreg-
ulation of the dopamine pathway in nNOS KO mice.
Methods
Animals and Experimental Design
nNOS KO (Strain Name: B6;129S4-Nos1tm1hlh/J, Stock
Number: 002633) mice were obtained from Jackson Lab-
oratories (Bar Harbor, ME) [23]. They were backcrossed
for five generations onto a C57BL/6J background. We
could not backcross for any more generations due to the
infertility of nNOS KO mice [47]. Genetic testing of two
nNOS KO mice confirmed that an average of 94.5% of the
markers corresponded to C57BL/6J (Genetic Testing Serv-
ices; Central Institute for Experimental Animals, Tokyo).
nNOS KO mice and wild-type control littermates were
obtained by breeding heterozygote mice. All behavioral
tests were carried out with male mice that were at least 7
weeks old at the start of testing. Raw data of the behavioral
test, the date on which each experiment was done, and the
age of the mice at the time of the experiment are shown in
the mouse phenotype database https://
behav.hmro.med.kyoto-u.ac.jp/. Mice were group housed
(2–4 mice per cage) in a room with a 12 hr light/dark cycle
(lights on at 7:00 a.m.) with access to food and water ad
libitum. Room temperature was kept at 23 ± 2°C. Behavio-
ral testing was performed between 9:00 a.m. and 6:00
p.m. After the tests, all apparatus was cleaned with diluted
sodium hypochlorite solution to prevent a bias due to
olfactory cues. We prepared four independent groups of
mice for behavioral tests. One group consisted of the
equivalent number of nNOS KO mice and wild-type con-
trol littermates. Experiments were done in the following
sequences; the first group: the general health and neuro-
logical screen including wire hang test (GHNS), light/dark
transition (LD), open field (OF), elevated plus maze (EP),
hot plate (HP), one-chamber social interaction test (SI),
rotarod (RR), startle response/prepulse inhibition test
(PPI), Morris water maze, social interaction test in home
cage (HC-SI) and latent inhibition test; the second group:
GHNS, LD, OF, EP, HP, SI, RR, PPI, Porsolt forced swim
test (PS), HC-SI and eight-arm radial maze; the third
group: GHNS, LD, OF, EP, SI, Crawley's sociability and
preference for social novelty test (CSI) and PPI with drug;
the forth group: GHNS, LD, OF, EP, SI, CSI and PPI with
drug. Each behavioral test was separated from each other
at least by 1 day. There were no significant interactions
between genotype and group in the results presented in
any figures (ANOVA, p > 0.05). All behavioral testing pro-
cedures were approved by the Animal Care and Use Com-
mittee of Kyoto University Graduate School of Medicine.
Behavioral testing
Open field test
Locomotor activity was measured using an open field test.
Each mouse was placed in the corner of the open field
apparatus (40 × 40 × 30 cm; Accuscan Instruments,
Columbus, OH). The chamber of the test was illuminated
at 100 lux. Total distance traveled (in cm), vertical activity
(rearing measured by counting the number of photobeam
interruptions), time spent in the center area, and beam-
break counts for stereotyped behaviors were recorded.
Data were collected for 120 min.
Light/dark transition test
A light/dark transition test was conducted as previously
described [48]. The apparatus used for the light/dark tran-
sition test comprised a cage (21 × 42 × 25 cm) divided
into two sections of equal size by a partition with a door
(Ohara & Co., Tokyo). One chamber was brightly illumi-
nated (390 lux), whereas the other chamber was dark (2
lux). Mice were placed into the dark side and allowed to
move freely between the two chambers with the door
open for 10 min. The total number of transitions, latency
to first enter the lit chamber, distance traveled, and time
spent in each chamber were recorded by Image LD4 soft-
ware (see 'Data analysis').
Elevated plus maze test
An elevated plus maze test was conducted as previously
described [49]. The elevated plus-maze consisted of two
open arms (25 × 5 cm) and two enclosed arms of the same
size with 15-cm high transparent walls. The arms and cen-
tral square were made of white plastic plates and were ele-
vated 55 cm above the floor. To minimize the likelihood
of animals falling from the apparatus, 3-mm high Plex-
iglas walls surrounded the sides of the open arms. Arms of
the same type were located opposite from each other.
Each mouse was placed in the central square of the maze
(5 × 5 cm), facing one of the closed arms. Mouse behavior
was recorded during a 10-min test period. The number of
entries into an arm, and the time spent in the open and
enclosed arms were recorded. Percentage of entries into
open arms, time spent in open arms (s), number of total
entries, and total distance traveled (cm) were analyzed.
Data acquisition and analysis were performed automati-
cally, using Image EP software (see 'Data analysis').
Social interaction test in a novel environment (one-chamber social 
interaction test)
In the social interaction test, two mice of identical geno-
types that were previously housed in different cages were
placed in a box together (40 × 40 × 30 cm) and allowed toMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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explore freely for 10 min. Social behavior was monitored
with a CCD camera connected to a Macintosh computer.
Analysis was performed automatically using Image SI soft-
ware (see 'Data analysis'). The total number of contacts,
total duration of active contacts, total contact duration,
mean duration per contact, and total distance traveled
were measured. The active contact was defined as follows.
Images were captured at 1 frame per second, and distance
traveled between two successive frames was calculated for
each mouse. If the two mice contacted each other and the
distance traveled by either mouse was longer than 2 cm,
the behavior was considered as 'active contact'.
Social interaction test in home cage
Social interaction monitoring in the home cage was con-
ducted as previously described [7]. The system comprised
the home cage (29 × 18 × 12 cm) and a filtered cage top,
separated by a 13-cm-high metal stand containing an
infrared video camera attached at the top of the stand.
Two mice of the same genotype that had been housed sep-
arately were placed together in a home cage. Their social
behavior was then monitored for 1 week. Output from the
video camera was fed into a Macintosh computer. Images
from each cage were captured at a rate of one frame per
second. Social interaction was measured by counting the
number of particles detected in each frame: two particles
indicated that the mice were not in contact with each
other; and one particle (i.e., the tracking software could
not distinguish two separate bodies) indicated contact
between the two mice. We also measured locomotor activ-
ity during these experiments by quantifying the number
of pixels that changed between each pair of successive
frames. Analysis was performed automatically using
Image HA software (see 'Data analysis').
Crawley's sociability and preference for social novelty test
The test for sociability and preference for social novelty
was conducted as previously described [50,51]. The appa-
ratus comprised a rectangular, three-chambered box and a
lid containing an infrared video camera (Ohara & Co.).
Each chamber was 20 × 40 × 22 cm and the dividing walls
were made from clear Plexiglas, with small square open-
ings (5 × 3 cm) allowing access into each chamber. An
unfamiliar C57BL/6J male (stranger 1) that had no prior
contact with the subject mouse was placed in one of the
side chambers. The placement of stranger 1 in the left or
right side chambers was systematically alternated between
trials. The stranger mouse was enclosed in a small, circular
wire cage that allowed nose contact between the bars, but
prevented fighting. The cage was 11 cm high, with a bot-
tom diameter of 9 cm and bars spaced 0.5 cm apart. The
subject mouse was first placed in the middle chamber and
allowed to explore the entire social test box for 10-min.
The amount of time spent within a 5-cm distance of the
wire cage and in each chamber. At the end of the first 10
min, each mouse was tested in a second 10-min session to
quantitate social preference for a new stranger. A second,
unfamiliar mouse was placed in the chamber that had
been empty during the first 10-min session. This second
stranger was enclosed in an identical small wire cage. The
test mouse had a choice between the first, already-investi-
gated unfamiliar mouse (stranger 1), and the novel unfa-
miliar mouse (stranger 2). As described above, the
amount of time spent within a 5-cm distance of each wire
cage and in each chamber during the second 10-min ses-
sion was recorded. The stranger mice used in this experi-
ment were 8 to 12-week-old C57BL/6J male mice, not
littermates. Analysis was performed automatically using
Image CSI software (see 'Data analysis').
Startle response/PPI test
A startle reflex measurement system was used (Ohara &
Co.). A test session began by placing a mouse in a Plex-
iglas cylinder where it was left undisturbed for 10 min.
The duration of white noise that was used as the startle
stimulus was 40 ms for all trial types. The startle response
was recorded for 140 ms (measuring the response every 1
ms) starting with the onset of the prepulse stimulus. The
background noise level in each chamber was 70 dB. The
peak startle amplitude recorded during the 140-ms sam-
pling window was used as the dependent variable. A test
session consisted of 6 trial types (i.e., two types for startle
stimulus-only trials, and four types for PPI trials). The
intensity of the startle stimulus was 110 or 120 dB. The
prepulse sound was presented 100 ms before the startle
stimulus, and its intensity was 74 or 78 dB. Four combi-
nations of prepulse and startle stimuli were employed
(74–110 dB, 78–110 dB, 74–120 dB, and 78–120 dB). Six
blocks of the 6 trial types were presented in a pseudoran-
dom order such that each trial type was presented once
within a block. The average inter-trial interval was 15 s
(range, 10–20 s).
In the PPI test with drug treatment, nNOS KO and wild-
type mice were assigned to receive either the selective D1
receptor agonist SKF81297 (1 mg/kg) or saline (balanced
for genotype, startle chamber assignment, and treatment)
and were tested for PPI 20 min later. SKF81297 was dis-
solved in saline, and both SKF81297 and saline were
administered intraperitoneally in an injection volume of
10 ml/kg.
Porsolt forced swim test
The Porsolt forced swim test apparatus consisted of four
Plexiglas cylinders (20 cm high × 10 cm diameter). A non-
transparent panel separated the cylinders to prevent the
mice from seeing each other (Ohara & Co.). The cylinders
were filled with water (23°C) up to a height of 7.5 cm.
Mice were placed into the cylinders, and their behavior
was recorded over a 10-min test period. Retention testsMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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were administered 24 hours after training (trial 2) and 1
week after the first test (trial 3). Data acquisition and anal-
ysis were performed automatically, using Image PS soft-
ware (see 'Data Analysis').
Eight-arm radial maze test
The eight-arm radial maze test was conducted to assess
spatial working memory in a manner similar to that
described previously [10]. The floor of the maze was made
of white Plexiglas and the wall (25 cm high) consisted of
transparent Plexiglas. Each arm (9 × 40 cm) radiated from
an octagonal central starting platform (12 cm/side) like
the spokes of a wheel. A guillotine door separated each
arm from the central starting platform. Identical food
wells (1.4 cm deep and 1.4 cm in diameter) with pellet
sensors were placed at the distal end of each arm. The pel-
lets sensors automatically recorded pellet intake by the
mice. The maze was elevated 75 cm above the floor and
placed in a dimly lit room with several extra-maze cues.
During the experiment, the maze was maintained in a
constant orientation. One week before pretraining, ani-
mals were deprived of food until their body weight was
reduced to 80% to 85% of the initial level. Pretraining
started on the 8th day. Each mouse was placed in the cen-
tral starting platform and allowed to explore and to con-
sume food pellets scattered across the whole maze for a
30-min period (one session per mouse). After completing
the initial pretraining, mice were given another pretrain-
ing session to take a pellet from each food well after being
placed at the distal end of each arm. A trial was finished
after the subject consumed the pellet. This was repeated 8
times, using 8 different arms, for each mouse. After these
pretraining trials, maze acquisition trials were performed.
All 8 arms were baited with food pellets. Mice were placed
on the central platform and allowed to obtain all 8 pellets
within 25 min. A trial was terminated immediately after
all 8 pellets were consumed or 25 min had elapsed. An
'arm visit' was defined as traveling more than 5 cm into
the arm from the edge of the central platform. The mice
were confined in the center platform for 5 s after each arm
choice. The animals were given one trial per day for 30
days (30 trials total). After the initial 30 trials, "delay tri-
als" were conducted during which the mice were confined
in the center platform for 30, 120, 300 s after performing
4 correct arm choices (2 trials for each delay). For each
trial, the number of different arms chosen among the first
8 choices and the number of revisiting errors were auto-
matically recorded. Data acquisition, control of guillotine
doors, and data analysis were performed by Image RM
software (see 'Data analysis').
Morris water maze test
The "hidden platform" version of the Morris water maze
test was conducted to assess spatial reference memory, as
described previously [52]. The apparatus consisted of a
circular tank (40 cm high × 95 cm diameter) filled with
water (up to 30 cm deep) maintained at room tempera-
ture (23 ± 2°C) that was made opaque with nontoxic
white paint. The surface of the platform (8 × 8 cm) was 1
cm below the water surface. Four trials per day were con-
ducted for 14 successive days with the same platform loca-
tion. There were four possible locations for the platform.
One of these platform positions was assigned to each
mouse as the correct location during the training. Latency
to reach the platform was recorded. When the distance
between the mouse and the wall of the pool was less than
8 cm, the mouse was considered to be at the perimeter.
On the 15th day, the platform was removed, and a 60-s
probe trial was conducted (probe test A). Time spent in
each quadrant was recorded during the probe trials. Four
training trials were conducted immediately after the probe
test A and another probe test (probe test B) was conducted
1 week after the initial probe test to evaluate memory
retention. Data acquisition and analysis were performed
using Image WM software (see 'Data analysis').
Data analysis
Behavioral data were obtained automatically by applica-
tions based on the public domain NIH Image program
and Image J program and modified for each test by Tsuy-
oshi Miyakawa (available through Ohara & Co.). Statisti-
cal analysis was conducted using StatView (SAS Institute,
Cary, NC). Data were analyzed by two-tailed t-test, two-
way ANOVA, or two-way repeated measures ANOVA. Val-
ues in graphs are expressed as mean ± SEM.
Analysis of protein phosphorylation in neostriatal slices
Preparation and incubation of neostriatal slices
Neostriatal slices were prepared from male wild-type and
nNOS KO mice at 9 to 12 weeks of age. The mice were
decapitated and the brains rapidly removed and placed in
ice-cold, oxygenated Krebs-HCO3
- buffer (124 mM NaCl,
4 mM KCl, 26 mM NaHCO3, 1.5 mM CaCl2, 1.25 mM
KH2PO4, 1.5 mM MgSO4, and 10 mM D-glucose, pH 7.4).
Coronal slices (350 μm) were prepared using a vibrating
blade microtome, VT1000S (Leica Microsystems, Nuss-
loch, Germany). The striatum was dissected from the
slices in ice-cold Krebs-HCO3
-  buffer. Each slice was
placed in a polypropylene incubation tube with 2 ml fresh
Krebs-HCO3
- buffer containing adenosine deaminase (10
μg/ml). The slices were preincubated at 30°C under con-
stant oxygenation with 95% O2/5% CO2 for 60 min. The
buffer was replaced with fresh Krebs-HCO3
- buffer after 30
min of preincubation. Adenosine deaminase was
included during the first 30 min of preincubation. Slices
were treated with drugs as specified in each experiment.
SKF81297 and glutamate were obtained from Sigma-
Aldrich (St. Louis, MO). After drug treatment, slices were
transferred to Eppendorf tubes, frozen on dry ice, and
stored at -80°C until assayed.Molecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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Immunoblotting
Frozen tissue samples were sonicated in boiling 1%
sodium dodecyl sulfate and boiled for an additional 10
min. Small aliquots of the homogenate were retained for
protein determination by the BCA protein assay method
(Pierce, Rockford, IL). Equal amounts of protein (100 μg)
were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (10% polyacrylamide gels), and trans-
ferred to nitrocellulose membranes (0.2 μm) (Schleicher
and Schuell, Keene, NH). The membranes were immuno-
blotted using phosphorylation state-specific antibodies:
phospho-Thr34 DARPP-32 antibody (mAb-23; 1:750
dilution) [53]; phospho-Thr75 DARPP-32 antibody
(1:5000 dilution) [54]; phospho-Ser845 GluR1 antibody
(#06-773; 1:1000; Upstate Cell Signaling Solutions, Lake
Placid, NY); phospho-ERK1/2 antibody (#9100; 1:2000
dilution; New England BioLabs, Beverly, MA); and phos-
pho-Ser94 spinophilin antibody (RU499; 1:4000 dilu-
tion) [55]. The membrane was reblotted with DARPP-32,
GluR1, ERK, or spinophilin antibody to determine the
total amount of those proteins. None of the experimental
manipulations used in the present study altered the total
amount of DARPP-32, GluR1, ERK, or spinophilin.
The membrane was incubated with a goat anti-mouse or
rabbit Alexa 680-linked IgG (1:5000 dilution; Molecular
Probes, Eugene, OR) or a goat anti-mouse or rabbit
IRDye™800-linked IgG (1:5000 dilution; Rockland, Gil-
bertsville, PA). Fluorescence at infrared wavelengths was
detected by the Odyssey infrared imaging system (LI-
COR, Lincoln, NE), and quantified using Odyssey soft-
ware. In an individual experiment, samples from control
and drug-treated slices were analyzed on the same immu-
noblot. For each experiment, values obtained for slices
were calculated relative to values for the control slices
from wild-type mice. Normalized data from multiple
experiments were averaged and statistical analysis was
performed as described in the figure legends.
Results
Increased locomotor activity in nNOS KO mice
Locomotor activity was examined in the open field test,
elevated plus maze, light/dark transition test, and social
interaction tests. nNOS KO mice showed a pronounced
increase in locomotor activity in several different tests.
Hyperactivity was consistently observed in all locomotor
activity-related indices measured. Compared with wild-
type control mice nNOS KO mice traveled significantly
longer distances in the open field test [Fig 1A; genotype
effect, F(1,55) = 26.395, p < 0.0001], in the lit compart-
ment in the light/dark transition test [Fig 1E; genotype
effect, F(1,55) = 5.392, p = 0.0240], and in the elevated
plus maze test [Fig 1K; genotype effect, F(1,49) = 9.068, p
= 0.0041]. The stereotypic counts in the open field test
[Fig 1B; genotype effect, F(1,55) = 9.389, p = 0.0034], and
the number of total arm entries in the elevated plus maze
test [Fig 1I; genotype effect, F(1,49) = 7.671, p = 0.0079]
were also significantly increased in nNOS KO mice. There
was no significant difference in vertical activity of the
open field test [Fig 1C; genotype effect, F(1,55) = 0.061, p
= 0.8061].
We also assessed anxiety-like behaviors in nNOS KO
mice. nNOS KO mice spent significantly more time in the
center of the open field apparatus [Fig 1D; genotype effect,
F(1,55) = 6.441, p = 0.014], which is considered to reflect
reduced anxiety-like behavior. The lack of nNOS, how-
ever, did not significantly affect the following indices: the
number of the light/dark transitions [Fig 1F; genotype
effect, F(1,55) = 0.016, p = 0.8986] and the total time
spent in the lit compartment [Fig 1G; genotype effect,
F(1,55) = 1.312, p = 0.2571] and first latency to enter the
light chamber [Fig 1H; genotype effect, F(1,55) = 0.001, p
= 0.9725] in the light/dark transition test, the percentage
of entries into the open arms [Fig 1J; genotype effect,
F(1,49) = 0.002, p = 0.9632], and time on open arms [Fig
1L; genotype effect, F(1,49) = 0.170, p = 0.6819] in the
elevated plus maze test, suggesting that anxiety-like
behavior is not altered in nNOS KO mice. Thus, the lack
of nNOS was not associated with consistent changes in
anxiety-like behavior. Increased time in the center of open
field in nNOS KO mice, however, might reflect hyperac-
tivity.
In the Porsolt forced swim test, increased immobility is
interpreted as a form of learned helplessness that reflects
depression-related behavior and/or increased stress-sensi-
tivity [56]. nNOS KO mice spent significantly less time
immobile than wild-type mice (Fig 2), demonstrating
decreased depression-related behavior in nNOS KO mice.
Moreover, nNOS KO mice traveled significantly longer
distances, indicating that nNOS KO mice display a hyper-
active phenotype under extremely stressful conditions.
Abnormal social behavior of nNOS KO mice
During the social interaction test in a novel environment,
nNOS KO mice traveled significantly longer distances [Fig
3D; genotype effect, F(1,25) = 12.430, p = 0.0017], and
both the number of contacts and the total duration of
active contacts between nNOS KO mice were greater than
those of wild-type mice [Fig 3C; genotype effect, F(1,25) =
4.424, p = 0.0457; Fig 3A; genotype effect, F(1,25) =
4.518, p = 0.0436], suggesting that nNOS KO mice were
hyperactive. The duration of contacts made by nNOS KO
mice, however, tended to be longer than that of wild-type
mice [Fig 3E; genotype effect, F(1.25) = 3.759, p = 0.0639]
and mean duration per contact was not significantly dif-
ferent [Fig 3B; genotype effect, F(1,25) = 0.013, p =
0.7507]. The findings could also be the result of hyperac-
tivity, as a previous meta-analysis data of over 1000 miceMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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showed a high correlation between locomotor activity
and the number of contacts or total duration of active con-
tacts in the social interaction test (unpublished data).
ANCOVA applied to the number of total contacts, with
total distance as a covariate, indicated that the interaction
between total distance and genotypes was not significant
(p = 0.713) and the effect of genotype did not remain after
including total distance traveled as the covariate in the
ANCOVA (p = 0.1102). Therefore, the increased number
of contacts of nNOS KO mice in the social interaction test
in a novel environment may be due to hyperactivity (Fig
3F).
We monitored social interaction in the home cage under
familiar conditions over a 6-day period. In the social inter-
action test in the home cage, time spent separated is usu-
ally increased when mice are active and decreased when
mice are sleeping. nNOS KO mice spent significantly less
time separated from each other than wild-type mice [Fig
3G; genotype effect, p < 0.0001] and locomotor activity
Increased locomotor activity in nNOS KO mice Figure 1
Increased locomotor activity in nNOS KO mice. (A-D) Open field test: total distance traveled (A), stereotypic behavior 
(B), vertical activity (C), and time spent in the center of the compartment (D) were recorded. (E-H) Light/dark transition test: 
distance traveled in the light/dark compartments (E), number of light/dark transitions (F), time spent in light compartment (G), 
and latency to enter the light compartment (H) were recorded. (I-L) Elevated plus maze test: number of arm entries (I), per-
centage of entry into open arms (J), distance traveled (K), and time spent on open arms (L) were recorded. The p values indi-
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was significantly lower in nNOS KO mice [Fig 3H; geno-
type effect, p = 0.0041]. These phenotypes were observed
both in the light period [Fig 3I, J; genotype effect, mean
number of particles, p = 0.0002; activity level, p = 0.0015]
and in dark period [Fig 3I, J; genotype effect, mean
number of particles, p = 0.0001; activity level, p = 0.0152].
Even at the same activity level, nNOS KO mice tended to
remain separated compared to wild-type, indicating that
the increased contact in nNOS KO mice was not due to
hyperactivity (Fig 3K). ANCOVA applied to the mean
number of particles detected, with activity level as a cov-
ariate, indicated a significant interaction between activity
level and genotype (p = 0.0122) and the effect of genotype
remained when activity was used as the covariate in the
ANCOVA (p < 0.0001). Analysis of the relationship
between activity level and the interaction between two
mice indicated that nNOS KO mice showed an increased
number of contacts at the same activity level compared to
wild-type mice in their home cage. These findings indicate
that nNOS deficiency induces an increase in social inter-
action in the familiar environment.
Crawley's three-chamber social approach test consists of
sociability test and a social novelty preference test. These
tests assess social interaction that is relatively independent
of locomotor activity compared to the other social inter-
action tests, because the preference of the mice can be
quantified based on the time spent around a wire cage
containing a stranger mouse vs. an empty cage in the
sociability test and stranger mouse vs. a familiar mouse
[50]. In the sociability test, both nNOS KO mice and wild-
type mice type demonstrated normal sociability [Fig 3L,
M; time spent around cage, with stranger vs. empty; wild-
type: t(26) = 3.804, p = 0.0008, nNOS KO: t(21) = 2.465,
p = 0.0224, paired-t test]. In nNOS KO mice, however,
social approach was decreased in the sociability test [time
Increased depression-related behavior in nNOS KO mice Figure 2
Increased depression-related behavior in nNOS KO mice. (A-C) Immobility and (D-F) distance traveled were 






































































￿Molecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
Page 9 of 20
(page number not for citation purposes)
Abnormal social behaviors in nNOS KO mice Figure 3
Abnormal social behaviors in nNOS KO mice. (A-F) Social interaction test in a novel environment (one-chamber social 
interaction test): total duration of active contacts (A), mean duration of each contact (B), number of contacts (C), total dis-
tance traveled (D), and total contact duration (E) were recorded. The relationship between distance traveled and number of 
contacts was plotted (F). The p values indicate genotype effect in two-way ANOVA (A-E). (G-I) Social interaction test in home 
cage: mean number of particles detected (G) and activity level (H) were recorded over 6 days. The averaged graph over 3 days 
of mean number of particles detected (I) and activity level (J). The relationship between activity level and number of particles 
was plotted (K). The p values indicate genotype effect in two-way repeated measures ANOVA (G-J). (L-V) Crawley's three-
chamber social approach test. In the sociability test (L-V), time spent around the empty cage or the cage containing a stranger 
(L, M) and time spent in the chamber with an empty cage or cage containing a stranger (N, O) were recorded. In the prefer-
ence for social novelty test (P-S), time spent around the cage containing a stranger (stranger 2) and the cage with a familiar 
mouse (stranger1) (P, Q) and time spent in the chamber with the cage containing a stranger (stranger 2) and the cage with a 
familiar mouse (stranger1) cage (R, S) were recorded. Distance traveled was recorded in both tests (T, U). The ratio of dis-
tance traveled in the sociability test to that traveled in the preference for social novelty test is shown (V). The p values indicate 
the difference between the cages (stranger side vs. empty side; L-O, stranger 2 side vs. stranger 1 side; P-S). The p values indi-

























































































































































































































































































































































































































































































































































AMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
Page 10 of 20
(page number not for citation purposes)
spent around the cage with the stranger, genotype effect,
F(1,47)= 5.15, p = 0.0279]. Consistently, nNOS KO mice
did not show a preference for the chamber with the
stranger [Fig 3N, O; time spent in chambers (stranger 1
side vs. empty cage side); wild-type mice: t(26) = 3.134, p
= 0.0042; nNOS KO mice: t(21) = 0.874, p = 0.3920,
paired-t test]. The distance traveled in the sociability test
was not significantly different between genotypes [Fig 3T;
genotype effect, F(1,47) = 1.541, p = 0.2206]. In the social
novelty preference test, wild-type mice tended to demon-
strate a preference for novelty [Fig 3P; time spent around
the cage containing stranger 1 vs. that containing stranger
2: t(26) = 1.969, p = 0.0597, paired-t test], whereas nNOS
KO mice did not [Fig 3Q; time spent around the cage con-
taining stranger 1 vs. that containing stranger 2: t(21) =
1.686, p = 0.1067, paired-t test]. A preference between
chambers was not detected in either genotype [Fig 3R,S;
time spent around cages, wild-type mice: t(26) = 1.234, p
= 0.2284, nNOS KO mice: t(21) = 1.592, p = 0.1262,
paired-t test]. Although there were no significant differ-
ence in the distance traveled in the sociability test (Figure
3T), nNOS KO mice traveled a greater distance in the nov-
elty preference test [Fig 3U; genotype effect, F(1,47) =
11.094, p = 0.0017]. The ratio of distance traveled in the
novelty preference test to the distance traveled in the
sociability test was higher in nNOS KO mice [Fig 3V; gen-
otype effect, F(1,47) = 5.439, p = 0.0240], suggesting that
nNOS KO mice habituated less than wild-type mice.
Performance deficits of nNOS KO mice in the memory 
tasks
In the eight-arm radial maze test (spatial working memory
task), the number of revisiting errors, in which subjects
returned to the arms that had been visited previously to
retrieve a food pellet, was not significantly different
between genotypes during trials without a delay [Fig 4A;
genotype effect, F(1,23) = 1.050, p = 0.3161; genotype ×
trial interaction, F(14,322) = 0.990, p = 0.4636]. The
number of different arm choices among the first 8 entries,
which is considered a measure of working memory that is
relatively independent of locomotor activity levels, and
the total number of arm choices were not significantly dif-
ferent between genotypes [Fig 4B; genotype effect, F(1,23)
= 2.100, p = 0.1608; genotype × trial interaction,
F(14,322) = 1.325, p = 0.1905]. On the other hand, both
the number of revisiting errors and the different arm
choices among the first 8 entries were significantly greater
in nNOS KO mice during trials with delays [Fig 4C; geno-
type effect, F(1,23) = 5.880, p = 0.0236; genotype × trial
interaction, F(2,46) = 1.837, p = 0.1708, Fig 4D; genotype
effect, F(1,23) = 5.985, p = 0.0225; genotype × trial inter-
action, F(2,46) = 1.350, p = 0.2693], suggesting that
nNOS KO mice have mildly impaired working memory.
In the Morris water maze (spatial reference memory task),
latency to locate the escape platform during hidden plat-
form training (for 14 successive days) in nNOS KO mice
was significantly greater than that in wild-type mice [Fig
4E; genotype effect, F(1,22) = 6.145, p = 0.0213; genotype
× trial interaction, F(13,286) = 1.174, p = 0.2981]. Probe
trials were performed on day 15 and day 23 (1 week after
the last trial). Both nNOS KO mice and wild-type mice
spent more time in the previously trained quadrant than
in the three untrained quadrants. Time spent in the previ-
ously trained quadrant was not significantly different
between genotypes on the probe trial of the day 15 [Fig 4F;
genotype effect, F(1,22) = 0.346, p = 0.5625]. nNOS KO
mice spent significantly less time in the trained quadrant
than wild-type mice on day 23 [Fig 4G; genotype effect,
F(1,22) = 7.636, p = 0.0133]. These data suggest that
nNOS KO mice have impaired spatial remote memory.
In the Porsolt forced swim test, nNOS KO mice showed
decreased depression-related behavior [Fig 2A–C; geno-
type effect, first trial: F(1,28) = 9.660, p = 0.0043, a day
after the first trial: F(1,28) = 18.554, p = 0.0002, 7 days
after the first trial: F(1,28) = 8.263, p = 0.0076]. nNOS KO
mice traveled a greater distance [Fig 2D–F; genotype
effect, first trial: F(1,28) = 7.901, p = 0.0089, a day after
the first trial: F(1,28) = 6.266, p = 0.0184, 7 days after the
first trial: F(1,28) = 7.816, p = 0.0093], reflecting the
hyperactivity in the nNOS KO mice. In the second and
third trials, immobility during the first minute was similar
to that during the last minute in the previous trial in wild-
type mice [immobility in last minute of the first trial vs.
immobility in first minute of the second trial, t(16) =
1.679, p = 0.1126; immobility in last minute of the sec-
ond trial vs. immobility in first minute of the third trial,
t(16) = 0.500, p = 0.6240, paired-t test], suggesting that
wild-type mice remembered the previous event. On the
other hand, nNOS KO mice showed less immobility dur-
ing the first 1 min in the second or third trials compared
to that during the last minute in the previous trial [immo-
bility during the last minute of the first trial vs. immobil-
ity during the first minute of the second trial, t(12) =
3.442, p = 0.0049; immobility during the last minute of
the second trial vs. immobility during the first minute of
the third trial, t(12) = 3.875, p = 0.0022, paired-t test].
This finding might indicate that nNOS KO mice have
impaired reference memory for stressful events.
Together, these data suggest that nNOS deletion impairs
spatial working memory, remote spatial reference mem-
ory and reference memory for stressful events.
Increased D1-mediated dopaminergic signaling in brain 
slices of nNOS KO mice
Glutamate and dopamine regulate DARPP-32 phosphor-
ylation in neostriatal neurons via the activation of multi-
ple signaling cascades [45]. To examine the effect of nNOS
deletion on glutamatergic and dopaminergic signaling,
we investigated the regulation of protein phosphorylationMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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by glutamate and a D1 receptor agonist in striatal slices
from nNOS KO mice (Fig 5).
Treatment of neostriatal slices from wild-type mice with
glutamate (5 mM) induced a rapid increase in DARPP-32
Thr34 phosphorylation after 30 s incubation, but the
effect was transient (Fig 5A, B). We previously reported
that the effects of glutamate are mediated via the activa-
tion of nNOS/NO/cGMP/PKG signaling [45]. The gluta-
mate-induced increase in Thr34 phosphorylation was
absent in nNOS KO mice. Other than the rapid and tran-
sient increase in Thr34 phosphorylation, the phosphor-
ylation levels of DARPP-32 at Thr34 and Thr75 under
basal conditions and during incubation with glutamate
were similar between wild-type and nNOS KO mice [gen-
otype effect on DARPP-32 Thr34, F(1, 31) = 0.4146, p =
0.1927; genotype effect on DARPP-32 Thr75, F(1, 32) =
0.01168, p = 0.6053; Fig 5B,C]. The D1 receptor agonist
SKF81297 (Fig 5D–I) increased the phosphorylation of
DARPP-32 at Thr34 (Fig 5E), GluR1 at Ser845 (Fig 5G),
ERK2 (Fig 5H), and spinophilin at Ser94 (Fig 5I), all of
which are phosphorylated by PKA, in both wild-type and
nNOS KO mice. The increases in DARPP-32 Thr34 and
GluR1 Ser845 phosphorylation were significantly higher
in nNOS KO mice than in wild-type mice [genotype effect
on DARPP-32 Thr34, F(1, 96) = 12.47, p = 0.0007; geno-
type effect on GluR1 Ser845, F(1, 94) = 9.199, p =
0.0032], but the increases in ERK2 and spinophilin Ser94
phosphorylation were similar between wild-type and
nNOS KO mice [genotype effect on ERK2, F(1, 94) =
2.491, p = 0.1189; genotype effect on spinophilin Ser94,
F(1, 96) = 0.6535, p = 0.4212] (Fig 5E,G–I)]. These results
suggest that dopamine D1 receptor signaling is upregu-
lated in the striatum of nNOS KO mice in a substrate spe-
cific manner.
Treatment of wild-type slices with SKF81297 decreased
DARPP-32 Thr75 phosphorylation, presumably via the
activation of PP-2A/B56δ by PKA and increased dephos-
phorylation of Thr75 [57,58] (Fig 5F). The SKF81297-
induced decrease in Thr75 phosphorylation was not
observed in striatal slices from nNOS KO mice [genotype
effect on DARPP-32 Thr75, F(1, 98) = 12.74, p = 0.0006],
suggesting that regulation of PP-2A activity by D1 recep-
tor/PKA signaling is also altered in nNOS KO mice.
Increased D1-mediated dopaminergic signaling in nNOS 
KO mice in the PPI test
Though low dose of D1 receptor agonist does not alter PPI
in mice [59], high dose of it disrupts PPI [60]. D1 receptor
Impaired remote spatial memory of nNOS KO mice Figure 4
Impaired remote spatial memory of nNOS KO mice. (A-D) Eight-arm radial maze test: total number of arms revisited 
(A, C) and different arm choices among the first 8 entries (B, C) during training were recorded. During trials 32–36, a delay 
was applied after of the first 4 pellets were consumed (C, D). (E-G) Morris water maze test: latency to escape (E) was 
recorded during training session and probe tests. Probe tests were conducted 1 day (F) and 7 days after the last training trial 
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antagonist also disrupted PPI [61,62]. Because dopamine
D1 receptor signaling seems to be upregulated in nNOS
KO mice, we examined the effect of D1 receptor agonist,
SKF81297, on PPI in nNOS KO mice. PPI is a cross-species
phenomenon in which the startle response is reduced
when the startle stimulus is preceded by a low intensity
prepulse, and is disrupted in certain neuropsychiatric dis-
orders that are characterized by abnormal sensorimotor
gating, such as schizophrenia [61]. The effect of dopamine
agonists on PPI differs between species, and D1 receptor
agonists disrupt PPI in mice [62-64]. nNOS KO mice and
wild-type mice were tested in the PPI test without drug
and with a low dose of the D1 receptor agonist SKF81297
(1 mg/kg, intraperitoneally). In the test without drug,
acoustic startle and PPI were not significantly different
across genotypes [Fig 6A; genotype effect, F(1,91) = 0.223,
p = 0.6383; Fig 6B; genotype effect, F(1,91) = 1.345, p =
0.2492 (110 dB), F(1,91) = 0.424, p = 0.5167 (120 dB)].
Wild-type mice showed a significantly decreased acoustic
startle response following injection with SKF81297 [Fig
6C; drug effect, F(1,29) = 5.336, p = 0.0282], but nNOS
KO mice did not (Fig 6E). Neither injection with saline
nor SKF81297 significantly altered PPI in wild-type mice
(Fig 6D). In contrast, PPI was disrupted in nNOS KO mice
after injection with SKF81297 [Fig 6F; drug effect, F(1, 25)
= 5.115, p = 0.0327 (120 dB)]. These data indicate that
PPI is easier to disrupt with a D1 receptor agonist in nNOS
KO mice compared to wild-type mice, and suggest that
nNOS KO mice have upregulated D1 mediated signaling.
Thus, increased D1-mediated dopaminergic signaling was
also demonstrated in nNOS KO mice at the behavioral
level.
Discussion
In the present study, nNOS KO mice exhibited increased
locomotor activity in the open field test. Hyperactivity of
nNOS KO mice was also consistently observed in other
tests, such as the light/dark transition, elevated plus maze,
and social interaction (novel environment) tests. To date,
locomotor activity of nNOS KO mice has not been well
examined. Although a few studies have reported on the
locomotor activity of nNOS KO mice [24,26,65], most of
the observations were either not quantitative and/or sub-
ject animals were not compared with appropriate control
animals. Nelson et al. reported that nNOS KO mice dis-
played normal locomotor activity, but they in fact
assessed locomotor balance and coordination [24]. In the
study by Bilbo et al., nNOS KO mice showed increased
locomotor activity in the open field test only in the second
test, performed during the dark phase, but not during the
light phase [65]. In addition, they compared nNOS KO
mice with non-littermate C57BL/6 controls. Comparing
behaviors between mutant mice and non-littermate mice
may lead to the detection of an effect of different environ-
ments rather than the mutation itself. Behavioral pheno-
typing of genetically engineered mice should be done
with control animals from the same standardized genetic
and environmental background as the engineered mice
[66,67]. Otherwise, an observed difference in the pheno-
type could be caused by differences in the breeding envi-
ronment or genetic background. Weitzdoerfer et al. used
an observational test battery and reported increased loco-
motor activity in nNOS KO mice [26]. Because their meth-
ods depended heavily on human observation, however,
the data were not quantitative. They used nNOS KO mice
with only three-generations of backcrossing [26]. In mice
from an N3 backcross, there is theoretically 12.5% of the
donor strain genome, therefore the phenotype could be
caused by flanking genes [68]. The donor strain of the
nNOS KO mice in their study was 129/Sv, which is
hypoactive compared to the C57BL/6 strain. The hyperac-
tivity of nNOS KO mice may have therefore been masked
by the low activity of the donor strain in their study. Mice
used in the present study were N5 backcrossed and had a
predominantly C57BL/6J genetic background (94.5%),
assessed by analyzing 100 microsatellite makers. Because
further backcrossing into C57BL/6J leads to low fertility in
nNOS KO mice, we could not backcross them further.
Gryuko et al. also reported that complete elimination of
nNOS, including splicing variants, caused infertility [47].
Pharmacologic studies indicate that administration of a
NOS inhibitor reduces locomotor activity in rodents [69-
71]. NOS inhibitors also cause a lack of motor coordina-
tion in rodents, assessed by the rotarod test [71]. There is
a high expression of nNOS in the cerebellum and motor
coordination is highly cerebellar-dependent. If adminis-
tration of an nNOS inhibitor induces an acute lack of
motor coordination, this may present as reduced locomo-
tor activity. In our study, although muscle strength, as
assessed by the grip strength test, was reduced in nNOS
KO mice, they performed normally in the rotarod test,
suggesting that other molecule(s) or residual splicing var-
iants of nNOS [47] compensate for the loss of nNOS.
With normal motor coordination, nNOS KO mice might
display increased locomotor activity. Kriegsfeld et al.
reported a deficit in the balance and coordination of
nNOS KO mice in a balance test on the pole and plank
only during the dark phase [25]. In our study, all experi-
ments except the home cage social interaction test were
performed during the light phase, therefore the effect of a
lack of motor coordination on locomotor activity in
nNOS KO mice, if any, would be smaller than that during
the dark phase.
Abnormal social behavior of nNOS KO mice
Although there are some studies reporting the social
behavior of nNOS KO mice [26,72] and the social behav-
ior of animals treated with nNOS inhibitors [72-75], the
results are inconsistent. Some studies report that treat-Molecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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Regulation of protein phosphorylation by glutamate and a D1 receptor agonist in brain slices from nNOS KO mice Figure 5
Regulation of protein phosphorylation by glutamate and a D1 receptor agonist in brain slices from nNOS KO 
mice. Neostriatal slices from wild-type (open circles) and nNOS KO (closed circles) mice were treated with glutamate (5 mM) 
(A-C) and a dopamine D1 receptor agonist, SKF81297 (1 μM; D-I) for the indicated times. Changes in the phosphorylation of 
DARPP-32 at Thr34 (B, E) and Thr75 (C, F), GluR1 at Ser845 (G), ERK2 (H), and spinophilin at Ser94 (I) were determined by 
Western blotting using phosphorylation-state specific antibodies. Typical immunoblots detected with phosphorylation-state 
specific and total DARPP-32 antibodies are shown in (A, D). Data represent means ± SEM for 3–9 experiments. *p < 0.05, **p 
< 0.01 compared with untreated slices (time 0) from wild-type mice; †p < 0.05, ††p < 0.01 compared with untreated slices 
(time 0) from nNOS KO mice; one-way ANOVA followed by Newman-Keuls test. §p < 0.05 compared with values of wild-
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ment with a NOS inhibitor decreases social interaction
behavior [72,75]; others report that treatment with a NOS
inhibitor [74] and nNOS knockout [26] does not affect
social interaction behavior; and still others report that
treatment with a NOS inhibitor increases social interac-
tion behavior [73]. These contradictory findings might be
the result of different methods or conditions used to
assess social behavior. Additionally, in most of the stud-
ies, only one kind of experiment was conducted, and
therefore it is difficult to compare the results between
them. In the present study, to assess social behavior of
nNOS KO mice in various situations, we conducted four
D1 receptor agonist-induced disruption of prepulse inhibition in nNOS KO mice Figure 6
D1 receptor agonist-induced disruption of prepulse inhibition in nNOS KO mice. Startle responses at 110 dB and 
120 dB were recorded (A). Startle response following 74 dB and 78 dB prepulse inhibition stimuli were recorded (B). Effect of 
SKF81297 administration on startle responses and prepulse inhibition in wild-type mice (C, D) and in nNOS KO mice (E, F). 
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kinds of social interaction tests. nNOS KO mice showed
1) an increased number of contacts and an increased total
duration of active contacts in a novel environment (one-
chamber social interaction test), which might reflect
hyperactivity, 2) increased social interaction behavior in
their home cage, and 3) decreased social approach behav-
ior in Crawley's three-chamber social approach test.
In the social interaction test in a novel environment (one-
chamber social interaction test), the mouse was exposed
to a stranger mouse in the chamber and both mice were
able to move freely. Weitzdoerfer et al. reported normal
social interaction behavior in nNOS KO mice [26]. Their
experimental conditions for the social interaction test
were similar to those of our one-chamber test. Although
the indices they used were the number of social behaviors
such as sniffing, grooming, mounting, rubbing, and fight-
ing, all of which are heavily dependent on human obser-
vation, their findings were consistent with ours.
The social interaction test in the home cage in the present
study revealed increased social interaction behavior in
nNOS KO mice. Although there are no reports of
increased social interactions in nNOS KO mice, a pharma-
cologic study showed that the administration of a NOS
inhibitor increases social interactions in rats [73]. The
finding that NOS inhibition in rats increases social inter-
actions in a novel environment, and nNOS deficiency in
mice increases social interactions in familiar environ-
ments may reflect an interspecies difference.
In the sociability test (three-chamber), the stranger mouse
was in a wire cage and was unable to move freely, and the
subject mouse could therefore approach the stranger
mouse. Additionally, because this test apparatus (three-
chamber) was larger than the one-chamber apparatus, the
subject mouse could remain far away from the stranger
than in the one-chamber social interaction test. This situ-
ation may decrease social investigative behavior in nNOS
KO mice. Although nNOS KO mice spent less time
around the stranger than the control mice, there was no
significant difference between genotypes in the time spent
around the empty cage and the distance traveled, indicat-
ing that nNOS KO mice showed normal exploration of
novel objects and novel environments. Therefore, the
decreased social investigative behavior of nNOS KO mice
was not due to neophobia.
In the social novelty preference test, a different stranger
mouse contained in a wire cage was added to the empty
chamber in the sociability test, and then the subject
mouse was allowed to explore the cage with the familiar
mouse and the cage with the stranger mouse. Distance
traveled by wild-type mice in the social novelty preference
test was reduced compared to that in the sociability test,
probably because those tests were conducted in succes-
sion. The ratio between the distance traveled in the social
preference test and that in the sociability test was higher
in nNOS KO mice than in control mice, indicating that
exploration was reduced less in nNOS KO mice than in
control mice. Impaired habituation of nNOS KO mice in
the three-chamber test may be interpreted as a cognitive
impairment. In a study by Bohme et al., rats treated with
an NOS inhibitor did not show reduced exploration of a
juvenile rat during a second exposure, suggesting that
NOS inhibition impaired social recognition [74]. Their
finding was consistent with ours in the social novelty pref-
erence test. nNOS inhibition also impairs olfactory learn-
ing [74], which might be reflected by the impaired
habituation of the nNOS KO mice in the present study.
Trainor et al. demonstrated decreased social interaction
behavior in nNOS KO mice [72] in which a stranger
mouse isolated by a wire barrier was introduced into the
home cage and the social behavior of nNOS KO mice was
observed. nNOS KO mice spent less time near the barrier
compared to control mice, indicating decreased social
investigation by the nNOS KO mice. Trainor et al.
reported a similar finding in mice administered an nNOS
inhibitor. Although their experiments were performed
using a home cage, the conditions of the test were similar
to those of our three-chamber sociability test regarding
the introduction of an animal into the cage. Thus, the
results of our three-chamber sociability test are consistent
with their findings, i.e., decreased social investigative
behavior by nNOS KO mice.
In the present study, nNOS KO mice showed abnormal
social behaviors, such as increased social interaction in their
home cage, decreased social investigation in a social prefer-
ence test, and normal social behaviors in the one-chamber
social interaction test. Together, the findings from the vari-
ous social behavior tests indicated that nNOS KO mice dem-
onstrate increased social behavior with a familiar mouse in
familiar conditions and they exhibit normal or mildly
decreased social behavior with an unfamiliar mouse. Dysreg-
ulated social behaviors are often observed in patients with
psychiatric disorders such as schizophrenia. Associations
between the nNOS gene and schizophrenia have been
reported [29,76-78]. Moreover, a recent study demonstrated
significantly more disruption or structural variants in genes
involved in NO signaling pathways in schizophrenic
patients than in normal controls [31], suggesting the
involvement of nNOS and NO signaling pathways in schiz-
ophrenia. Thus, abnormal nNOS function might be
involved in dysregulated social behavior in a subpopulation
of schizophrenic patients.
Impaired reference memory retention and working 
memory in nNOS KO mice
The eight-arm radial maze task is a hippocampus-depend-
ent task that is generally used to evaluate working mem-Molecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
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ory in rodents [79,80]. Both nNOS KO and wild-type mice
exhibited normal working memory when the delay
between each arm choice was 5 s. nNOS KO mice exhib-
ited mild deficits in working memory, however, when the
delay was increased to 30 s.
Spatial reference memory is frequently assessed by the
hidden platform version of the Morris water maze,
another test dependent on hippocampal function [81]. In
a previous study, nNOS KO mice showed deficits in reach-
ing the hidden platform 10 to 14 days after training in the
Morris water maze; although memory immediately after
training was not examined, the findings were interpreted
as a memory recall deficit [26]. In the same study, nNOS
KO mice performed well in a multiple T-maze test, a less
stressful spatial task, leading the authors to conclude that
the memory deficit of the nNOS KO mice was observed
only under stressful conditions [26]. In the present study,
however, both nNOS KO and wild-type mice spent signif-
icantly more time in the targeted quadrant than in the
other three quadrants 1 day after the last training (day
15), indicating that the nNOS KO mice are able to learn,
remember, and recall the platform location normally with
short retention delays, even under stressful conditions.
Further, these findings indicate that the spatial memory
deficit of the nNOS KO mice is not likely due to an abnor-
mal sensitivity to stress. On the other hand, nNOS KO
mice failed to search the target quadrant 7 days after the
last training (day 23), suggesting that the nNOS KO mice
have impaired memory retention rather than impaired
memory recall. These results are consistent with an idea
that NO acts as an important retrograde message for long-
term potentiation (LTP) [13] In hippocampal slices of
nNOS KO mice, NO-dependent LTP was only slightly
reduced, but otherwise normal, probably because the lack
of NO was compensated for by the endothelial isoform of
NO (eNOS) [82-84] or by residual nNOS splice variants
[85]. A recent study revealed a potential role of nNOS in
late-phase LTP [86], a finding that is consistent with the
behavior of nNOS KO mice in the water maze test in the
present study, because late-phase LTP involvement is
implicated in the maintenance/storage of long-term
memory [87].
Increased D1 receptor-mediated protein phosphorylation 
in nNOS KO mice
Activation of dopamine D1 receptors stimulates cAMP/
PKA signaling, leading to the phosphorylation of PKA
substrates such as DARPP-32 at Thr34 and GluR1 at
Ser845 in striatal neurons [37]. Phosphorylation of
DARPP-32 and GluR1 induced by the activation of
dopamine D1 receptors was enhanced in nNOS KO mice
compared to wild-type mice. However, enhanced D1
receptor/PKA signaling was not detected in the analysis of
spinophilin Ser94 and ERK2 phosphorylation. The bio-
chemical study clearly demonstrated that D1 receptor/
PKA signaling in nNOS KO mice is upregulated in striatal
neurons, although the upregulation is substrate-specific.
The increase in D1 receptor/PKA signaling detected in the
striatum of nNOS KO mice could be applied for brain
regions involved in PPI, and supports the findings of D1
receptor-mediated disruption of PPI in nNOS KO mice. In
addition, activation of the D1 receptors is known to
induce an increase in locomotor activity [88] and a
decrease in depression-related behavior in the forced
swim test [89]. Hyperactivity and a decrease in depres-
sion-related behavior in Porsolt forced swim test,
observed in nNOS KO mice, might be explained by the
upregulated D1 receptor signaling.
As nNOS deletion in somatostatin-positive interneurons
and the subsequent reduction of NO/guanylyl cyclase/
cGMP/PKG signaling in medium spiny neurons upregu-
lates D1 receptor/PKA signaling in the striatum, it is pos-
sible that the NO/PKG pathway has an inhibitory
influence on D1 receptor/adenylyl cyclase/cAMP/PKA sig-
naling in medium spiny neurons, leading to the suppres-
sion of DARPP-32 Thr34 and GluR1 Ser845
phosphorylation. Thus, the NO/PKG pathway has bidirec-
tional effects on DARPP-32 Thr34 phosphorylation: PKG
and PKA phosphorylate DARPP-32 at Thr34, whereas
PKG likely inhibits D1 receptor/adenylyl cyclase/cAMP/
PKA signaling upstream of DARPP-32. The molecular
mechanisms by which PKG modifies D1 receptor/adeny-
lyl cyclase/cAMP/PKA signaling require further elucida-
tion.
Activation of dopamine D1 receptors decreases the phos-
phorylation of DARPP-32 at Thr75 (Cdk5-site) via PKA-
dependent activation of PP-2A/B56δ [57,58]. In agree-
ment, DARPP-32 Thr75 phosphorylation was decreased
by D1 receptor activation in wild-type mice. In contrast,
nNOS KO mice did not show any changes in DARPP-32
Thr75 phosphorylation after D1 receptor activation. The
findings are different from the predicted results, because
PKA signaling is upregulated and PKG signaling, which
increases DARPP-32 Thr75 phosphorylation [90], is
downregulated in nNOS KO mice. The reason for the lack
of Thr75 dephosphorylation in response to D1 receptor
activation in nNOS KO mice is unknown. Phospho-Thr75
DARPP-32 inhibits PKA, and the inhibition is removed
when D1 receptor/PKA signaling is activated [57]. The
positive feedback loop for PKA activation seems to be
impaired in nNOS KO mice possibly due to the high PKA
tone. Alternatively, it is possible that activity of PP-2A/
B56δ is modulated by PKG, although highly speculative.
PPI of an acoustic startle induces a reduced startle
response to the startle stimulus when the stimulus is
immediately preceded by a weaker prestimulus [91]. PPIMolecular Brain 2009, 2:19 http://www.molecularbrain.com/content/2/1/19
Page 17 of 20
(page number not for citation purposes)
is naturally observed in humans and other animals
including rodents, but it is often disrupted in psychiatric
disorders such as schizophrenia [92]. PPI is disrupted by
pharmacologic manipulations with a psychotomimetic
drug, phencyclidine, and dopamine agonists [61]. The
role of nNOS in the behavioral effect of phencyclidine has
been investigated using the NOS inhibitor and nNOS KO
mice. A NOS inhibitor, L-NAME, blocked the phencyclid-
ine-induced decrease in PPI [93,94]. Interestingly, the
effect of phencyclidine in nNOS KO mice was opposite
[95]. In that study, treatment with phencyclidine
increased PPI in nNOS KO mice but not in wild-type con-
trol mice [95]. Although there is a discrepancy between
studies using the NOS inhibitor and nNOS KO mice,
those studies demonstrate that nNOS/NO signaling plays
a critical role in the regulation of PPI.
In the present study, activation of D1 receptors with a low
dose of SKF81297 disrupted PPI in nNOS KO mice, but
not in wild-type mice. A number of studies demonstrated
that manipulations of dopamine signaling alter PPI in
rodents [59-62,64], and pharmacologic studies indicate
the relationship between high dopamine signaling and
disruption of PPI [61]. SKF81297, a D1 agonist, in a rela-
tively high dose compared to that used in the present
study, decreased PPI [60], whereas the D1 antagonist
increased PPI in rats [96,97]. It is likely that dopamine D1
receptor signaling is upregulated in nNOS KO mice as
demonstrated by biochemical studies, and therefore PPI is
disrupted in nNOS KO mice in response to a low dose of
SKF81297.
There are several studies that report abnormal behavior of
hyperdopaminergic mice. Dopamine transporter (DAT)
knockdown mice, that are known as hyperdopaminergic,
displayed hyperactivity [98,99], perseverative motor
behavior [99], and impaired response habituation [98]. In
addition, DAT knockout mice also showed hyperactivity,
perseverative motor behavior, disrupted prepulse inhibi-
tion, and high sensitivity to D1 receptor antagonist [100].
Behavioral phenotypes observed in nNOS KO mice, such
as hyperactivity, perseverative motor behavior (increased
stereotypic behavior in open filed test), impaired habitu-
ation in three-chamber social interaction test, and hyper-
sensitivity to D1 receptor antagonist in PPI test, resemble
those in DAT knockdown and knockout mice, suggesting
the hyperdopaminergic state of nNOS KO mice.
Conclusion
nNOS KO mice were subjected to a battery of behavioral
tests. nNOS KO mice exhibited hyperactivity, impaired
memory, decreased depression-related behavior, abnor-
mal social behavior and D1 receptor-mediated disruption
of PPI. Biochemical analysis in the striatum revealed the
upregulation of dopamine D1 receptor/PKA signaling in
nNOS KO mice. Some of behavioral abnormalities in
nNOS KO mice such as hyperactivity, decreased depres-
sion-related behavior and D1 receptor-mediated disrup-
tion of PPI might be explained by high activity of
dopamine D1 receptor/PKA signaling.
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